Table 2. Type and distribution of lesions within the study population.
Number | Percentage | ||
---|---|---|---|
Benign | Granulomatous lymphadenitis | n = 1 | 4.% |
Compacted breast tissue | n = 2 | 9.1% | |
(n = 22) | Ductal hyperplasia | n = 2 | 9.1% |
(52%) | Fibroadenoma | n = 6 | 27.3% |
Fibrosis | n = 5 | 22.7% | |
Fibrocystic mastopathia | n = 2 | 9.1% | |
Papilloma | n = 3 | 13.6% | |
Fat tissue | n = 1 | 4.5% | |
Malignant | |||
n = 29 | Invasive ductal carcinoma (IDC)* | n = 26 | 89.6% |
(58%) | carcinoma in situ (DCIS) | n = 1 | 3.4% |
Invasive lobular carcinoma | n = 2 | 6.8% | |
Lesion Size | Mean | SD | |
Benign | 11.54 mm | 4.03 mm (range 4.9–21.7) |
|
Malignant | 12.56 mm | 5.17 mm (range 6.3–21.3) |